	Label	Description
	G43417UB Compound (Entity type)	type="BaseComposition" mass="383.142760805" permass="495.267961365" monosaccharides="2" is_motif="Fa...
	G29068FM Compound (Entity type)	type="BaseComposition" mass="221.089937305" permass="291.168187655" monosaccharides="1" is_motif="Fa...
	G27391WQ Compound (Entity type)	type="BaseComposition" mass="424.16930991" permass="536.29451047" monosaccharides="2" is_motif="Fals...
	APOA HUMAN Protein (Entity type)	Apolipoprotein(a) (precursor)
	p08519-1 16ser 16ser defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification

G43417UB

type="BaseComposition" mass="383.142760805" permass="495.267961365" monosaccharides="2" is_motif="Fa...

G29068FM

type="BaseComposition" mass="221.089937305" permass="291.168187655" monosaccharides="1" is_motif="Fa...

G27391WQ

type="BaseComposition" mass="424.16930991" permass="536.29451047" monosaccharides="2" is_motif="Fals...

APOA HUMAN

Apolipoprotein(a) (precursor)

p08519-1 16ser 16ser defined go:0006486 go:0006493

A Post Translational Modification

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.